STOCKSCREENR
Log In

VVOS

NASDAQ

Vivos Therapeutics, Inc.

$1.32+0.02(+1.54%)Mkt Cap: $7.77M

Key Stats

Market Cap

$7.77M

P/E Ratio

-0.75

EPS

$-1.77

Dividend Yield

0.00%

52-Week Range

$1.19 — $7.95

Volume

93.43K

Avg Volume

119.83K

Beta

7.02

Valuation

P/E (TTM)

-0.75

Forward P/E

—

PEG Ratio

0.17

P/S (TTM)

0.42

P/B (TTM)

5.37

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-3.51%

ROA (TTM)

-0.67%

ROIC

—

Gross Margin

0.56%

Operating Margin

-0.91%

Net Margin

—

Debt/Equity

4.94

Current Ratio

0.78

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.43%

EPS Growth (5Y)

+0.24%

Sales Growth (3Y)

-0.03%

Sales Growth (5Y)

+0.07%

EPS Est (This Year)

$-1.25

EPS Est (Next Year)

$0.00

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.28

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

5.89M

Float

3.19M

Free Float %

54.21%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2020-12-11

Employees

109

CEO

R. Kirk Huntsman

Index Membership

—

Website

https://vivos.com

Vivos Therapeutics, Inc. (VVOS) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $7.77M, a P/E ratio of -0.75, VVOS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VVOS against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NXL

Nexalin Technology, Inc.

$0.41

+0.57%

$7.63M

HSCS

HeartSciences Inc.

$2.65

-0.37%

$5.95M

BBLG

Bone Biologics Corporation

$1.24

+1.64%

$2.23M

AIDX

20/20 Biolabs, Inc. Common Stock

$2.16

-13.60%

$10.61M

PLSM

Pulsenmore Ltd. Ordinary Shares

$4.20

-2.33%

$27.31M

LFWD

Lifeward Ltd.

$7.56

+2.30%

$11.53M

Frequently Asked Questions

What is Vivos Therapeutics, Inc.'s P/E ratio?

Vivos Therapeutics, Inc. (VVOS) has a trailing twelve-month (TTM) P/E ratio of -0.75. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Vivos Therapeutics, Inc. pay a dividend?

No, Vivos Therapeutics, Inc. (VVOS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Vivos Therapeutics, Inc.'s market cap?

Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $7.77 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.